U.S. EPA Finalizes Dioxin Assessment

EPA has issued its assessment of dioxin’s noncancer health effects, part of an effort that has been in progress for more than 20 years and represents one of industry’s longest running and most contentious disputes with regulators. The cancer portion of the assessment, part of EPA's efforts under the Integrated Risk Information System (IRIS), is due out at a later, unspecified date. ACC says it is concerned because EPA's noncancer assessment of dioxin sets a recommended exposure level that is nearly three times more stringent than the levels set by...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers